S6(R1) Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals
S6(R1) Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals- S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals (PDF - 137 KB) posted 11/01/97
- S6 Addendum to Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals (PDF 182 KB) posted 5/17/2012
Note: In June 2011, the ICH incorporated the S6 Addendum with S6 and retitled the combined document S6(R1). The contents of S6 and the S6 Addendum reflect the contents of S6(R1).
Back to: International Conference on Harmonisation - Safety
No hay comentarios:
Publicar un comentario